Tag: Canada

– Transdev Canada expands into Manitoba for the first time with the acquisition of Patient Transport Services

Transdev Canada announces the acquisition of Patient Transport Services, the largest Non-Emergency Medical transportation company in Manitoba, operating in Winnipeg, Brandon and Carman. WEBWIRE – Monday, May 6, 2024 Present in 6 provinces and 1 territory, Transdev Canada has 4,700 employees operating in the Transit, Student, Paratransit, Medical and rail sectors, notably following the recent acquisition of the activities of First Transit. Transdev is also the operator of the future Hurontario tramway in the Greater Toronto Area, as a member of the Mobilinx consortium, and of the future Ontario Line Metro as a member of the Connect 6ix consortium. WithPatient ... Read more

McDonald’s Canada and its independent Franchisees are supporting communities impacted by the wildfires

WEBWIRE – Thursday, June 8, 2023 Across Alberta, Nova Scotia, and most recently, Quebec and Ontario, communities and individuals continue to grapple with the impact of wildfires. McDonalds independent Franchisees and restaurant teams have been hard at work supporting guests and restaurant team members in these impacted communities. We also know that some of our McDonalds Canada team members have been affected by the fires. And so, as we have for over 55 years, well rally together to support our local Franchisees, their teams, and communities in times of disaster. Here is how Franchisees and their teams responded first and ... Read more

Japan – Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc. announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the U.S.: LEQEMBI), an investigational anti-amyloid beta (Aβ) protofibril* antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) with confirmed amyloid pathology in the brain. The NDS is based on the results of the Phase III Clarity AD study and Phase IIb clinical study (Study 201), which demonstrated the lecanemab treatment showed a reduction of clinical decline in early AD. Lecanemab selectively binds and eliminates soluble, ... Read more

Canada Asset Management Group Opens New Research Office in Toronto

 Canada Asset Management Group’s recent opening of a research center in Toronto’s financial district, Exchange Tower, marks a significant milestone in the company’s history. The Hong Kong-based firm, founded in 2013, has decided to retrace its roots and expand its services to offer clients the highest quality research and analysis to maintain its position as a market leader in the financial industry. The company’s Chief Trading Director, Peter Jennings, emphasized the importance of the opening of the research center, by stating that it is a pivotal and special moment in the firm’s history. The new research center will now enable ... Read more

GM Canada Sales Increase 42% in Q4, and 5% for 2022

OSHAWA, Ont. – WEBWIRE – Wednesday, January 4, 2023 Chevrolet, Buick, GMC and Cadillac dealers delivered228,003 vehicles in 2022, including 55,724 vehicles in the fourth quarter, up 5 per cent and 42 per cent, respectively. Our sales demonstrate the teams success increasing vehicle availability to meet strong customer demand, said Sandor Piszar, vice president, sales, service and marketing, GM Canada. As a result of those efforts, as well as working closely with our GM Canada dealers, we grew retail sales by 31 per cent this quarter, compared to Q4 2021 and more than doubled our commercial fleet sales for the ... Read more